申请人:Richter Gedeon Vegyeszeti Gyar Rt.
公开号:US04183909A1
公开(公告)日:1980-01-15
The invention relates to novel peptides of formula (I), A-Try-B-Asp-Phg-NH.sub. 2 (I) wherein A is tert.-butoxycarbonyl-aminooxy-acyl, benzyloxycarbonyl-aminooxy-acyl, (aminooxy)-acyl or E-aminooxy-acyl, wherein E is benzoyl or straight-chained or branched C.sub.1-5 aliphatic acyl, and B represents methionyl, leucyl, norleucyl, norvalyl or 2-amino-decanoyl, or acid addition salts or complexes thereof. The novel compounds according to the invention exert gastrin effects and can be applied to advantage in the diagnostics and therapy. The novel compounds of formula (I) are prepared according to the invention by reacting a tetrapeptideamide of formula (II), H-Try-B-Asp-Phg-NH.sub. 2 (II) wherein B is as defined above, with an (aminooxy)-acyl containing compound of the general formula A.sub.1 -X, wherein A.sub.1 has the same meanings as A with the exception of the (aminooxy)-acyl, and X is hydroxy group, halogen, pivaloyloxy, a group of the formula R--O--CO.sub.2 -- (wherein R is lower alkyl, phenoxy which can have a nitro substituent or one or more halogen or N-succinimidoxy.
本发明涉及公式(I)的新肽,A-Try-B-Asp-Phg-NH.sub.2(I),其中A是tert.-butoxycarbonyl-aminooxy-acyl,benzyloxycarbonyl-aminooxy-acyl,(aminooxy)-acyl或E-aminooxy-acyl,其中E是苯甲酰基或直链或支链C.sub.1-5脂肪酰基,B代表甲硫氨酰基,亮氨酰基,诺亮氨酰基,诺缩氨酰基或2-氨基癸酰基,或其酸加成盐或络合物。本发明的新化合物具有胃泌素效应,并可优势地应用于诊断和治疗。公式(I)的新化合物是通过将公式(II)的四肽酰胺,H-Try-B-Asp-Phg-NH.sub.2(II),其中B如上所定义,与含有(aminooxy)-acyl的化合物A.sub.1-X反应而制备的,其中A.sub.1除了(aminooxy)-acyl外具有与A相同的含义,X是羟基,卤素,皮瓦酰氧基,公式R-O-CO.sub.2-(其中R是低碳基,苯氧基可以有一个硝基取代基或一个或多个卤素或N-琥珀酰氧基)。